Market revenue in 2023 | USD 1,611.5 million |
Market revenue in 2030 | USD 2,685.0 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Insulin delivery devices |
Fastest growing segment | Insulin Delivery Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Blood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices |
Key market players worldwide | Medtronic PLC, Abbott Laboratories, Roche Holding AG, Bayer AG, Johnson & Johnson, B. Braun, DexCom Inc, Insulet Corp, Ypsomed Holding AG, Sanofi SA, Novo Nordisk A/S ADR, Arkray |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes devices market will help companies and investors design strategic landscapes.
Insulin delivery devices was the largest segment with a revenue share of 54.19% in 2023. Horizon Databook has segmented the Germany diabetes devices market based on blood glucose monitoring (bgm) devices, insulin delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.
Germany has a lucrative environment for technologically innovative startups. Around 80% of the medical device manufacturers, including companies of diabetes devices, in the country, are SMEs. The presence of major market players, such as B Braun Melsungen AG and Abbott Laboratories, is anticipated to create lucrative opportunities in Germany.
In addition, funding available through G-BA (Gemeinsamer Bundesausschuss) is expected to boost the demand for diabetes devices in Germany. Several companies are opting for reimbursement for their diabetes devices in the country. For instance, in March 2021, Nemaura Medical, Inc. submitted application for G-BA for reimbursement in Germany for its glucose monitoring device, sugar BEAT.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany diabetes devices market , including forecasts for subscribers. This country databook contains high-level insights into Germany diabetes devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account